Structural analysis of main protease from delta and gamma coronaviruses

A team of US-based scientists has recently determined the inhibitor-bound crystal structures of the Main proteases (Mpro) of delta and gamma coronaviruses isolated from mammals. The study is currently available on the bioRxiv* preprint server.   

Study: Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses. Image Credit: Lightspring/Shutterstock
Study: Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses. Image Credit: Lightspring/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

Coronaviruses are zoonotic viruses that can cause severe respiratory, gastrointestinal, and hepatic infections in animals and humans. Zoonotic transmission of coronaviruses from animals to humans has caused three major outbreaks, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the ongoing coronavirus disease 2019 (COVID-19) pandemic. 

Deadly viral species responsible for these outbreaks belong to the beta-coronavirus family. Alpha-coronaviruses are also known to cause mild respiratory infections in humans. Viral species from the delta and gamma genera have recently been found to infect mammals.

The delta-coronavirus HKU15 and gamma-coronavirus SW1 have been isolated from porcine and beluga whale, respectively. Since these mammals live near humans, there remains a risk of further zoonotic transmission of these viruses to humans. Thus, structural characterization of these viruses and identification of active sites to design pan-coronavirus inhibitors are the need of the hour.

In the current study, scientists have determined crystal structures of inhibitor-bound Mpro derived from HKU15 and SW1.

Crystal structures of Mpro from delta- and gamma-coronaviruses  

The crystal structure of gamma-coronavirus Mpro was determined with or without a covalent inhibitor bound at the active site.

The structural analysis of inhibitor-bound Mpro revealed that the active site positioned between domains I and II in both protomers is accessible for ligand binding and that the C-terminal helical domain III facilitates dimerization.

The inhibitor was converted to the aldehyde and occupied two active sites through covalent attachment to the catalytic Cys142.  

The structural analysis of delta-coronavirus Mpro revealed that the inhibitor binds at the active site with a binding mode similar to that observed in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the COVID-19 pandemic. Despite similar binding modes, a variation in the degree of packing was observed between the two viral variants because of the differences in amino acid sequences at respective active sites.

Overall, the analyses indicated that the covalent small molecule inhibitors bind to respective Mpro variants in their canonical binding mode with minor rearrangements.

Comparison of Mpro structures between coronaviruses

The study analysis identified that the amino acid sequences and structures in the S2 subsite of Mpro are highly different between beta-, delta-, and gamma-coronaviruses. This subsite comprised residues from the 180s loop, which is adaptable and changes conformation depending on the substrate peptide or inhibitor bound.

The other part of the S2 subsite comprised residues from the 40s loop, which are highly variable between coronaviruses. These variations indicate that optimization of the P2 position of covalent inhibitors to generate pan-coronavirus inhibitors is the most challenging task. 

Specifically, the broad activity of inhibitors depends on the shared leucine moiety at their P2 position. Any modifications at this position to increase the efficacy of an inhibitor against a specific variant may abrogate its binding to other Mpro variants.   

Based on these observations, the scientists suggest that the leucine moiety at the P2 position should be maintained while designing potential pan-coronavirus inhibitors.

The structural analysis of substrate-bound Mpro of SARS-CoV-2 conducted in the study revealed that many of the currently available inhibitors protrude from the substrate envelope at the P2 position. These protrusions are responsible for the emergence of resistance mutations and suppression of pan-coronavirus activity.

Study significance

The study provides crystal structures of inhibitor-bound Mpro variants from porcine-derived delta-coronavirus and beluga whale-derived gamma-coronavirus. These two mammal-infecting coronaviruses are believed to originate from birds. Since both porcine and whale live near humans, the risk of further zoonotic transmission of these viruses to humans cannot be ignored.

Devastating outcomes of the ongoing COVID-19 pandemic have signified the need for developing pan-coronavirus inhibitors. In this context, the current study findings provide information for designing such inhibitors. Mpro is an attractive target for developing pan-coronavirus inhibitors as its structure is highly conserved between coronaviruses.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 17 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, May 17). Structural analysis of main protease from delta and gamma coronaviruses. News-Medical. Retrieved on October 03, 2024 from https://www.news-medical.net/news/20230203/Structural-analysis-of-Main-Protease-from-delta-and-gamma-coronaviruses.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Structural analysis of main protease from delta and gamma coronaviruses". News-Medical. 03 October 2024. <https://www.news-medical.net/news/20230203/Structural-analysis-of-Main-Protease-from-delta-and-gamma-coronaviruses.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Structural analysis of main protease from delta and gamma coronaviruses". News-Medical. https://www.news-medical.net/news/20230203/Structural-analysis-of-Main-Protease-from-delta-and-gamma-coronaviruses.aspx. (accessed October 03, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Structural analysis of main protease from delta and gamma coronaviruses. News-Medical, viewed 03 October 2024, https://www.news-medical.net/news/20230203/Structural-analysis-of-Main-Protease-from-delta-and-gamma-coronaviruses.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?